BRIEF-BioNap consulting's Jason Napodano issues an update on BriaCell Therapeutics

Tue Sep 27, 2016 8:57am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Sept 27 (Reuters) - Briacell Therapeutics Corp

* BioNap consulting's Jason Napodano issues an update on BriaCell Therapeutics Corp

* Expects to initiate a phase I/IIa program with BriaVax in Q4 of 2016

* Says BriaCell is currently completing final stages of manufacturing of vaccine for clinical study Source text for Eikon: Further company coverage: